Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H34O2S |
Molar mass | 374.58 g·mol−1 |
3D model (JSmol) | |
| |
|
Tinabinol (INN; SP-119) is a synthetic cannabinoid drug and analogue of dronabinol and dimethylheptylpyran which was patented as an antihypertensive but was never marketed.[1][2]